• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服给儿童接种的灭活大肠杆菌0111:K58疫苗的免疫原性。

Immunogenicity of a killed E. coli 0111:K58 vaccine administered orally to children.

作者信息

Iannuzzi C, Barbaro S, Viano I, Zucca M, Marazzi M G, Fonzo D, Campelli A, Lenti Bologna M, Dianzani F

出版信息

G Batteriol Virol Immunol. 1979 Jan-Jun;71(1-6):100-6.

PMID:385407
Abstract

A killed E. coli 0111:K58 vaccine was administered by the oral route to 16 children ranging from 3 months to 7 years of age. The antibody response was measured at different times after the vaccination through the titration of agglutinating antibodies in serum and in fecal extracts, and the detection of specific IgA immunoglobulins in the intestinal content. All vaccines developed antibody response detectable both inserum and in fecal samples. Coproantibodies tended to appear earlier and to attain higher titers than circulating antibodies; they were all least in part IgA immunoglobulins, since the content of specific IgA in the fecal extracts was proportional to the agglutinating titer.

摘要

将一种灭活的大肠杆菌0111:K58疫苗经口服途径给予16名年龄在3个月至7岁之间的儿童。在接种疫苗后的不同时间,通过滴定血清和粪便提取物中的凝集抗体以及检测肠道内容物中的特异性IgA免疫球蛋白来测量抗体反应。所有疫苗在血清和粪便样本中均产生了可检测到的抗体反应。粪便抗体往往比循环抗体出现得更早且滴度更高;它们至少部分是IgA免疫球蛋白,因为粪便提取物中特异性IgA的含量与凝集滴度成正比。

相似文献

1
Immunogenicity of a killed E. coli 0111:K58 vaccine administered orally to children.口服给儿童接种的灭活大肠杆菌0111:K58疫苗的免疫原性。
G Batteriol Virol Immunol. 1979 Jan-Jun;71(1-6):100-6.
2
Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group.口服灭活全细胞产肠毒素大肠杆菌加霍乱毒素B亚单位疫苗:儿童初步评估结果。PRIDE研究组
J Infect Dis. 1999 Jan;179(1):107-14. doi: 10.1086/314543.
3
Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.口服灭活全细胞重组B亚单位霍乱疫苗在哥伦比亚巴兰基亚的安全性和免疫原性。
Bull Pan Am Health Organ. 1995 Dec;29(4):312-21.
4
[Oral immunization of rabbits against enteropathogenic serotypes of E. coli. II. Production of circulating and fecal antibodies induced with monovalent and polyvalent vaccines].[兔针对致病性大肠杆菌血清型的口服免疫。II. 单价和多价疫苗诱导产生的循环抗体和粪便抗体]
G Batteriol Virol Immunol. 1975 Jul-Dec;68(7-12):305-10.
5
Effects of an orally administered live Escherichia coli pilus vaccine on duration of lacteal immunity to enterotoxigenic Escherichia coli in swine.口服活大肠杆菌菌毛疫苗对猪对产肠毒素大肠杆菌乳源性免疫持续时间的影响。
Am J Vet Res. 1988 Dec;49(12):2068-71.
6
[Oral immunization of human adult volunteers using a trivalent coli-vaccine].[使用三价大肠杆菌疫苗对成人志愿者进行口服免疫]
G Batteriol Virol Immunol. 1976 Jan-Jun;69(1-6):85-90.
7
Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli.向志愿者施用产肠毒素大肠杆菌的纯化定居因子抗原(CFA/I、CFA/II)。对强毒性产肠毒素大肠杆菌攻击的反应。
Gastroenterology. 1984 Oct;87(4):934-40.
8
Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.初免-加强疫苗方案可赋予针对人源产肠毒素大肠杆菌的保护性免疫。
Vaccine. 2005 Mar 31;23(19):2430-8. doi: 10.1016/j.vaccine.2004.11.026.
9
[Experimental study of the course of the immune response at the urinary level following repeated oral vaccination].[重复口服疫苗接种后泌尿水平免疫反应过程的实验研究]
Minerva Med. 1990 Nov;81(11):791-800.
10
Safety and immunogenicity of Escherichia coli O157 O-specific polysaccharide conjugate vaccine in 2-5-year-old children.大肠杆菌O157 O特异性多糖结合疫苗在2至5岁儿童中的安全性和免疫原性。
J Infect Dis. 2006 Feb 15;193(4):515-21. doi: 10.1086/499821. Epub 2006 Jan 13.